Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

S. Kaye, S. Aamdal, R. Jones, G. Freyer, E. Pujade-Lauraine, E.G.E. de Vries, J. Barriuso, S. Sandhu, D.S.W. Tan, V. Hartog, B. Kuenen, R. Ruijter, G.B. Kristensen, M. Nyakas, S. Barrett, W. Burke, D. Pietersma, M. Stuart, U. Emeribe, E. Boven

Research output: Contribution to journalArticleAcademicpeer-review

66 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1728-1734
JournalBritish Journal of Cancer
Volume106
Issue number11
DOIs
Publication statusPublished - 2012

Cite this

Kaye, S., Aamdal, S., Jones, R., Freyer, G., Pujade-Lauraine, E., de Vries, E. G. E., ... Boven, E. (2012). Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours. British Journal of Cancer, 106(11), 1728-1734. https://doi.org/10.1038/bjc.2012.158